Z-1018-2025 Class II Ongoing

Recalled by Randox Laboratories, Limited — Crumlin

FDA device recall Z-1018-2025 was initiated by Randox Laboratories, Limited on Dec 20, 2024 and is designated Class II. Reason for recall: Lipoprotein (a) on Roche Cobas c501 with nmol/l claims does not have a 510(k) or PMA. The recall status is ongoing. Affected quantity: 33 kits.

Recall details

Product Type
Devices
Report Date
Jan 29, 2025
Initiation Date
Dec 20, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
33 kits

Product description

Randox Lipoprotein (a) - In vitro diagnostic (IVD) use as Randox Lipoprotein (a) assay on automated analysers. Catalog Number: LP2757

Reason for recall

Lipoprotein (a) on Roche Cobas c501 with nmol/l claims does not have a 510(k) or PMA.

Distribution pattern

US Nationwide distribution Including PR.

Code information

UDI-DI: 05055273209198 All lots within expiry

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1018-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1018-2025. Report a data issue: hello@regdatalab.com.